The healthcare landscape has undergone a rapid transformation worldwide over the past decade. COVID-19 played a massive role ...

Gilead may collaborate with Galapagos to develop Ouro's in-licensed gamgertamig for the treatment of B-cell mediated autoimmune diseases.

Monash University and ClinChoice have announced a strategic partnership to accelerate clinical development of new therapies.

Sanofi and Kali Therapeutics have signed an exclusive global licence agreement for KT501, a new tri-specific antibody for B cell-mediated autoimmune diseases.

Fast-track qualifications are becoming a popular option for people wanting to start “real life” faster. Compared to traditional degree programs, they allow you to finish your education faster. If ...

Backed by partner Sanofi, Earendil will expand the utility of its AI-driven drug discovery platform, while progressing its ...

ImmunityBio has received approval from the Macau Special Administrative Region for Anktiva in combination with BCG for bladder cancer.

BMS's Opdivo has received approvals for two new indications in cHL from the US FDA and the EC, expanding its use for both paediatric and adult patients.

An expert involved in the first successful gene therapy trial for Huntington's Disease discusses the trial results and ...

Wegovy HD’s approval came on the cusp of the drug’s patent expiry in India and China, which leaves it open to some biosimilar ...

Clinical trial data managers must prepare for the use of AI in processes. Credit: via Shutterstock. AI in clinical trials has the potential to offer faster insights, greater efficiency, and improved ...

Novartis has signed an agreement to acquire SNV4818, a pan-mutant selective Phosphoinositide 3-kinase alpha (PI3Kα) inhibitor ...